MDCC Molecular Devices (MM)

SUNNYVALE, Calif., April 24 /PRNewswire-FirstCall/ -- Molecular Devices Corporation (NASDAQ:MDCC), a leader in innovative solutions for drug discovery and life sciences research, today announced that Joseph D. Keegan, Ph.D., CEO and President, will present at the Deutsche Bank Securities 31st Annual Health Care Conference on Tuesday, May 2, 2006 at 7:30 AM (EDT) at the Sheraton Hotel in Boston. Molecular Devices' audio presentation will be webcast live, and can be accessed at: http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=MDCC&item_id=1272028 or on the investor page at the Company's website http://www.moleculardevices.com/. The presentation will be archived on the Company's website for 5 days. Molecular Devices Corporation is a leading supplier of high-performance bioanalytical measurement systems that accelerate and improve drug discovery and other life sciences research. The Company's systems and consumables enable pharmaceutical and biotechnology companies to leverage advances in genomics, proteomics and parallel chemistry to facilitate the high-throughput and cost-effective identification and evaluation of drug candidates. The Company's solutions are based on its advanced core technologies that integrate its expertise in engineering, molecular and cell biology and chemistry. Molecular Devices enables its customers to improve research productivity and effectiveness, which ultimately accelerates the complex process of discovering and developing new drugs. DATASOURCE: Molecular Devices Corporation CONTACT: Tim Harkness of Molecular Devices Corporation, +1-408-747-3533 Web site: http://www.moleculardevices.com/

Copyright